Rapid generation of monocyte-derived antigen-presenting cells with dendritic


Fast technology of monocyte-derived antigen-presenting cells with dendritic cell-like properties Background: One of many main challenges in mobile remedy is the institution and validation of easy and quick manufacturing protocols assembly good manufacturing apply (GMP) necessities. Dendritic cells (DCs) are of specific therapeutic curiosity, as

Rapid Antigen Detection Test for Severe Acute Respiratory Syndrome


Analysis of fast SARS-CoV-2 antigen assessments, AFIAS COVID-19 Ag and ichroma COVID-19 Ag, with serial nasopharyngeal specimens from COVID-19 sufferers We evaluated the diagnostic accuracy of two newly developed, point-of-care, fast antigen assessments (RATs) for detecting SARS-CoV-2, the AFIAS COVID-19 Ag and the ichromaTM COVID-19 Ag,

Assay for Screening of Blood Donors for Hepatitis B Surface Antigen Seropositivity


Comparative Evaluation of Fast Check and Enzyme Linked Immunosorbent Assay for Screening of Blood Donors for Hepatitis B Floor Antigen Seropositivity   Background: The Hepatitis B floor Antigen (HBsAg) is essentially the most utilized indicator marker of hepatitis B an infection. This examine assesses the accuracy of

Rapid Antigen Test as Screening Strategy at Points of Entry


COVID-19 Speedy Antigen Take a look at as Screening Technique at Factors of Entry: Expertise in Lazio Area, Central Italy, August-October 2020 COVID-19 pandemic is a dramatic well being, social and financial international problem. There may be pressing want to maximise testing capability. Speedy Antigen

Imbalance between inflammatory and regulatory cord blood B cells following pre-term birth

Preterm birth (PTB) is one of the most frequent pregnancy complications. It affects millions of babies each year worldwide and is associated with increased morbidity and mortality. PTB-associated alterations in the maternal immune response may have a direct effect on the developing

Cancer immunology

Cancer heterogeneity It enables clonal survival and treatment resistance, is shaped by active immune responses. Antigen-specific T cells can control cancer, as revealed clinically by immunotherapeutics such as adoptive T–cell transfer and checkpoint blockade. Host immune system IT is thus a powerful